Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Investigators, TAUROS MRI"'
Autor:
Höglinger, Günter U, Huppertz, Hans-Jürgen, Villoria, R., de Yebenes, J García, Lopez Sendón, J. L., Tolosa, E., Buongiorno, M. T., Bargalló, N., Burguera, J. A., Martinez, I., Ruiz-Martínez, J., Villanua, J., Wagenpfeil, Stefan, Vivancos, F., Ybot, I., Aguilar, M., Dolz, J. L., Boada, M., Lafuente, A., Tejero, M. A., López-Lozano, J. J., Mata, M., Kupsch, A., Andrés, María V, Lipp, A., Höllerhage, M., Oertel, W. H., Respondek, G., Stamelou, M., Knake, S., Berg, D., Maetzler, W., Srulijes, K. K., Gröger, A., Belloch, Vincente, Ludolph, A., Kassubek, J., Steiger, M., Tyler, K., Burn, D. J., Morris, L., Lees, A., Ling, H., Strycharczuk, L., León, Teresa, Del Ser, Teodoro, Investigators, TAUROS MRI, G'mez, J. C., Tijero, B.
Publikováno v:
Movement disorders 29(4), 479-487 (2014). doi:10.1002/mds.25815
It is believed that glycogen synthase kinase-3 hyperphosphorylates tau protein in progressive supranuclear palsy (PSP). The Tau Restoration on PSP (TAUROS) trial assessed the glycogen synthase kinase-3 inhibitor tideglusib as potential treatment. For